Here are 7 updates about ketamine therapy that Becker's has reported since May 10:
- Nue Life Health raised $23 million to expand its telehealth platform devoted to developing the use of ketamine therapy. The company currently offers treatment in Washington, Colorado, New York, California, Texas and Florida and plans to expand to 26 states by the end of the year.
- Ascend Wellness, run by Melinda Howe, CRNA, was the first ketamine therapy clinic in Minot, N.D. The clinic uses intravenous ketamine infusions for patients with severe, treatment-resistant mental health and chronic pain conditions.
- Supplements company Irwin Naturals acquired Salem, N.H.-based ketamine therapy clinic New England Ketamine in May. In November, the company bought Dura Medical's clinic in Naples, Fla. The company now has 13 locations across Florida, Georgia, Idaho, Iowa, New Hampshire, Ohio and Vermont.
- Jayesh Kamath, MD, PhD, a professor of psychiatry at the University of Connecticut in Mansfield, called the use of ketamine as a treatment for mental health "revolutionary" for how quickly it can work for patients with severe depression.
- A study found that telehealth at-home ketamine therapy sessions are a safe and "incredibly effective" treatment for depression and anxiety. Here are more of the study's findings.
- Massachusetts General Hospital and Brigham and Women’s Hospital, both based in Boston, will use $50 million to study the efficacy of using electroconvulsive therapy and intravenous ketamine to treat suicidality and bipolar disorder.
7. Franklin, Tenn.-based Acadia Healthcare will participate in a clinical trial for intranasal ketamine. The study will evaluate the effectiveness of the drug for treating suicidal ideation and major depression.